About

Director since November 2020. Former Chief Commercial Officer of Kite Pharma and Pharmacyclics; former CEO and board member of CoRegen. Serves on the board of Cabaletta Bio.

Roles

4D Molecular Therapeutics, Inc.
Director · Current role
2020–present

Director Compensation

FY 2025
Fees earned or paid in cash
$62,500
Option awards
$70,000
Total
$132,500

Also at 4D Molecular Therapeutics, Inc.

Colleague
David Kirn, M.D.
Co-Founder, President, Chief Executive Officer and Director
Colleague
John F. Milligan, Ph.D.
Director and Executive Chairman
Colleague
Jacob Chacko, M.D., MBA
Director

Related

Company
4D Molecular Therapeutics, Inc.
Company hub

See how VectorShift works for your firm

Request Demo